Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Inv. presentation
|
|
KIORA PHARMACEUTICALS INC (KPRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
4
| Tosca Melissa (EVP Finance) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 30,000 shares
@ $0
Granted 60,000 options to buy
@ $0.5677, valued at
$34.1k
|
|
| 10/03/2023 |
4
| Daniels Eric Joseph (Chief Development Officer) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 62,500 shares
@ $0
Granted 125,000 options to buy
@ $0.5677, valued at
$71k
|
|
| 10/03/2023 |
4
| Strem Brian M. (President and CEO) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 75,000 shares
@ $0
Granted 150,000 options to buy
@ $0.5677, valued at
$85.2k
|
|
| 10/03/2023 |
4
| TYLE PRAVEEN (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 5,000 options to buy
@ $0.5677, valued at
$2.8k
|
|
| 10/03/2023 |
4
| Shapiro Aron (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 5,000 options to buy
@ $0.5677, valued at
$2.8k
|
|
| 10/03/2023 |
4
| Stengone Carmine N. (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 8,000 options to buy
@ $0.5677, valued at
$4.5k
|
|
| 10/03/2023 |
4
| Hollander David (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted options to buy
@ $0.5677, valued at
$0 |
|
| 10/03/2023 |
4
| Gayron Kenneth L (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 5,000 options to buy
@ $0.5677, valued at
$2.8k
|
|
| 10/03/2023 |
4
| Parsons Erin (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 5,000 options to buy
@ $0.5677, valued at
$2.8k
|
|
| 03/07/2023 |
4
| Parsons Erin (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 8,000 options to buy
@ $3.83, valued at
$30.6k
|
|
| 03/07/2023 |
4
| Tosca Melissa (EVP Finance) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 2,400 shares
@ $0
Granted 1,600 options to buy
@ $3.83, valued at
$6.1k
|
|
| 03/07/2023 |
4
| Strem Brian M. (President and CEO) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 15,600 shares
@ $3.83, valued at
$59.7k
Granted 10,400 options to buy
@ $3.83, valued at
$39.8k
|
|
| 03/07/2023 |
4
| Daniels Eric Joseph (Chief Development Officer) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 15,600 shares
@ $0
Granted 10,400 options to buy
@ $3.83, valued at
$39.8k
|
|
| 03/07/2023 |
4
| Gayron Kenneth L (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 8,000 options to buy
@ $3.83, valued at
$30.6k
|
|
| 03/07/2023 |
4
| Shapiro Aron (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 8,000 options to buy
@ $3.83, valued at
$30.6k
|
|
| 03/07/2023 |
4
| TYLE PRAVEEN (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 8,000 options to buy
@ $3.83, valued at
$30.6k
|
|
| 03/07/2023 |
4
| Hollander David (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 8,000 options to buy
@ $3.83, valued at
$30.6k
|
|
| 03/07/2023 |
4
| CHANEY PAUL G (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 8,000 options to buy
@ $3.83, valued at
$30.6k
|
|
| 10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4
| Romano Sarah (CFO) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 108 shares
@ $0.69, valued at
$74.5 |
|
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| TYLE PRAVEEN (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 5,000 options to buy
@ $0.77, valued at
$3.9k
|
|
| 02/03/2022 |
4
| CHANEY PAUL G (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Granted 5,000 options to buy
@ $0.77, valued at
$3.9k
|
|
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2022 |
4
| Romano Sarah (CFO) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 114 shares
@ $1.08, valued at
$123.1 |
|
| 01/06/2022 |
4
| FROM STEPHEN (Executive Chairman) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 326 shares
@ $1.08, valued at
$352.1 |
|
| 12/08/2021 |
4
| FROM STEPHEN (Executive Chairman) has filed a Form 4 on KIORA PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 273 shares
@ $1.3, valued at
$354.9 |
|
|
|
|